Archived news features

  • During January 2023, the CIDG published one new protocol and one new review in Issue 1 2023 of the Cochrane Database of Systematic Reviews. Further details are below.New protocolInbaraj LR, Daniel J,Rajendran P, Bhaskar A, Srinivasalu VA, Narayanan MKS, Shewade HD, Kirubakaran R,Scandrett K, Malaisamy M, Takwoingi Y,...
    February 1 2023
  • What is the aim of this review?The aim of this Cochrane Review was to assess if diarrhoea is reduced by sanitation interventions to provide, upgrade, or encourage people to use toilets or latrines. We collected and analysed all relevant studies of certain prespecified rigorous study design types and found 51 studies involving 238,535 people.Key...
    January 25 2023
  • Cochrane Colloquium London 2023Cochrane UK is delighted to be hosting the Cochrane Colloquium at the Queen Elizabeth II (QEII) Centre in London from 4th to 6th September 2023, and Satellite events on 3rd September.We have chosen the theme ‘Forward together for trusted evidence’ to explore the challenges for the future around...
    January 24 2023
  • In this ‘Meet the CIDG staff’ feature, we talk with Dr Rebecca Kuehn.Rebecca joined the CIDG editorial base in Liverpool in November 2021 as a Research Associate. She attained a Bachelor of Medical Studies and Doctor of Medicine at the University of New South Wales, Australia. She then completed primary care postgraduate clinical training, is...
    January 12 2023
  • During November 2022, the CIDG published one new protocol, one new review, and two updated reviews in Issue 11 2022 of the Cochrane Database of Systematic Reviews. Further details are below. New protocolChen Ting-Ting I, Swai JK, Msellemu D, Lobo NF, Bradley J, Moore SJ. Volatile pyrethroid spatial repellents for malaria prevention....
    November 30 2022
  • Cephalosporin antibiotics for the treatment of enteric fever (typhoid fever)Key messages• There may be no difference in the performance of ceftriaxone (a type of cephalosporin) compared with azithromycin, fluoroquinolones, or chloramphenicol (other antimicrobial medicines) for adults and children with enteric fever (typhoid fever).• Cefixime (...
    November 30 2022
  • As the end of 2022 approaches, the Cochrane Infectious Diseases Group (CIDG) editorial base in Liverpool conveys thanks to its readers, authors, referees, and Editors for their continued support to the CIDG’s work. In this 2022 newsletter, we reflect on the past 12 months, and consider the year ahead.The evidence/pasta synthesis team (L-R):...
    November 22 2022
  • What is the diagnostic accuracy of antibody tests for the detection of infection with the COVID‐19 virus?BackgroundCOVID‐19 is an infectious disease caused by the SARS‐CoV‐2 virus that spreads easily between people in a similar way to the common cold or ‘flu’. Most people with COVID‐19 have a mild‐to‐moderate respiratory illness, and some may have...
    November 21 2022
  • In this ‘Meet the CIDG staff’ feature we chat with Tilly Fox, who joined the CIDG editorial base as a Research Assistant in June 2021. In June 2022, Tilly was appointed CIDG Review Synthesis Delivery Specialist, responsible for guiding Cochrane Reviews through the production and publication cycle and providing support to review authors. Tilly has...
    November 21 2022
  • Which permanent and temporary changes to the water environments of immature mosquitoes work better to reduce malaria in people?Why is it important to reduce malaria in people?Malaria has a very high impact on the health of the public, mostly in people in Africa and Asia. Strategies to reduce malaria have been studied for many years. Most...
    November 14 2022

Pages

Subscribe to Our news